Ashigarakami-gun, Japan

Mikinaga Mori

USPTO Granted Patents = 15 

 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 159(Granted Patents)


Location History:

  • Kanagawa, JP (2013)
  • Kanagawa-ken, JP (2014)
  • Ashigarakami-gun, JP (2019 - 2023)

Company Filing History:


Years Active: 2013-2025

where 'Filed Patents' based on already Granted Patents

15 patents (USPTO):

Title: The Innovative Mind of Mikinaga Mori: Advancements in Liposome Technology

Introduction

Mikinaga Mori, a prominent inventor based in Ashigarakami-gun, Japan, has made significant contributions to the field of biopharmaceuticals through his innovative work on liposome compositions and methodologies. With a remarkable portfolio of 13 patents, Mori's inventions are pushing the boundaries of cancer treatment and drug delivery systems.

Latest Patents

Mori’s latest patents focus on liposome compositions designed to improve drug delivery methods. One of his notable inventions is a liposome composition that includes a nucleic acid analog anticancer agent with an excellent leakage rate. This patented method outlines specific ratios of lysophospholipids and nucleic acid agents, enhancing the efficacy of drug release at a controlled rate of 2 to 10 mass%. Additionally, he developed another liposome composition aimed at long-term preservation and controlled release rates of drugs through hyper-osmotic conditions, allowing for effective treatment over extended periods.

Career Highlights

Mikinaga Mori works at Fujifilm Corporation, a renowned company in the field of advanced imaging and information technology. His role within the organization has allowed him to leverage his expertise in biopharmaceuticals, aligning with the company's goals to innovate and enhance therapeutic solutions.

Collaborations

Throughout his career, Mori has collaborated with notable colleagues, including Takeshi Matsumoto and Makoto Ono. These partnerships have fostered a collaborative environment that encourages the exchange of ideas, further driving innovation in liposome technology and its applications in medicine.

Conclusion

Mikinaga Mori's inventive prowess and commitment to advancing liposome technologies have positioned him as a leading figure in the pharmaceutical industry. His patents not only represent significant technical advancements but also hold promise for improving cancer therapies and enhancing patient care. As the field of biopharmaceuticals continues to evolve, Mori's contributions will undoubtedly play a crucial role in shaping the future of drug delivery systems.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…